CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
The objective of this study is to estimate the R0 resection rate in patients with Resectable Pancreatic Ductal Adenocarcinoma (R-PDAC) as we...
Phase 2
New York, New York, United States and 3 other locations
to determine the 18 week progression-free survival rate of the combination of BXCL701 and pembrolizumab in patients with pancreatic ductal adenocarcinoma...
Phase 2
Hackensack, New Jersey, United States and 2 other locations
(MMRp)/microsatellite stable (MSS) locally advanced rectal adenocarcinoma. The investigators will also find out whether BOT/BAL is an effect...
Phase 2
New York, New York, United States and 6 other locations
with chemotherapy and chemoradiation in locally advanced esophageal adenocarcinoma to examine the safety and efficacy of the combination of ...
Phase 2
New York, New York, United States and 3 other locations
with neoadjuvant chemotherapy for the treatment of treatment-naïve subjects with borderline resectable and locally advanced pancreatic ductal adenocarcinoma...
Phase 1
Lake Success, New York, United States and 1 other location
The goal of this study is to learn about of the research study drug, telomelysin (OBP-301), in combination with pembrolizumab in advanced or metastat...
Phase 2
New York, New York, United States
The purpose of this study is to compare overall survival of quemliclustat, nab-paclitaxel and gemcitabine versus placebo, nab-paclitaxel and gemcitab...
Phase 3
New York, New York, United States and 32 other locations
to evaluate the safety and efficacy of first-line chemo-immunotherapy combinations in participants with metastatic pancreatic ductal adenocarcinoma...
Phase 1
New York, New York, United States and 5 other locations
adenocarcinoma. Participants will receive immunotherapy (cemiplimab) which activates the body's immune system to attack cancer cells. Cemip...
Phase 2
New York, New York, United States and 1 other location
and practical (feasible) before surgical removal (resection) of lung adenocarcinoma (ADC). The researchers will also look at how the treatme...
Phase 1
New York, New York, United States and 6 other locations
Clinical trials
Research sites
Resources
Legal